Literature DB >> 15033998

Production of cell lines secreting TAT fusion proteins.

Tibor Barka1, Edward S Gresik, Scott C Henderson.   

Abstract

Transduction of proteins and other macromolecules constitutes a potent technology to analyze cell functions and to achieve therapeutic interventions. In general, fusion proteins with protein transduction domains, such as TAT, are produced in a bacterial expression system. Here we describe the generation of a mammalian expression vector coding for TAT-EGFP fusion protein. Transfection of CHO-K1 cells by this vector and subsequent selection by Zeocin resulted in cell lines that express and secrete EGFP, a variant of the green fluorescent protein GFP. The ultimate cell line was produced by first cloning the stable integrants and subsequent selection of EGFP-expressing cells by flow cytometric sorting. In the resulting cell line approximately 98% of cells express EGFP. Using the same methodology, we generated cell lines that express DsRed fluorescent protein. The advantages of using such a mammalian expression system include the ease of generating TAT fusion proteins and the potential for sustained production of such proteins in vitro and, potentially, in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033998     DOI: 10.1177/002215540405200405

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity.

Authors:  Ying Shen; William Yu; John G Hay; Harald Sauthoff
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

3.  Delivery of therapeutic proteins as secretable TAT fusion products.

Authors:  Marcella Flinterman; Farzin Farzaneh; Nagy Habib; Farooq Malik; Joop Gäken; Mahvash Tavassoli
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

4.  Development of a cell permeable competitive antagonist of RhoA and CRMP4 binding, TAT-C4RIP, to promote neurite outgrowth.

Authors:  Mohammad R Khazaei; Samuel Montcalm; Adriana Di Polo; Alyson E Fournier; Yves Durocher; Stephan Ong Tone
Journal:  J Mol Neurosci       Date:  2015-02       Impact factor: 3.444

5.  Secretory TAT-peptide-mediated protein transduction of LIF receptor α-chain distal cytoplasmic motifs into human myeloid HL-60 cells.

Authors:  Q Sun; J Xiong; J Lu; S Xu; Y Li; X P Zhong; G K Gao; H Q Liu
Journal:  Braz J Med Biol Res       Date:  2012-06-21       Impact factor: 2.590

6.  A novel CAV derived cell-penetrating peptide efficiently delivers exogenous molecules through caveolae-mediated endocytosis.

Authors:  Gaowei Hu; Wenlv Zheng; Ao Li; Yaru Mu; Mingyu Shi; Tuofan Li; Haitao Zou; Hongxia Shao; Aijian Qin; Jianqiang Ye
Journal:  Vet Res       Date:  2018-02-13       Impact factor: 3.683

7.  Construction of chicken infectious anemia virus infectious clone and study on its pathogenicity.

Authors:  Jinjin Wang; Yan Li; Yawen Zhang; Longfei Chen; Lichun Fang; Shuang Chang; Yixin Wang; Peng Zhao
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

Review 8.  Inhibition of regulated cell death by cell-penetrating peptides.

Authors:  Stefan Krautwald; Christin Dewitz; Fred Fändrich; Ulrich Kunzendorf
Journal:  Cell Mol Life Sci       Date:  2016-04-05       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.